328 related articles for article (PubMed ID: 23526304)
1. Uterine perforation caused by intrauterine devices: clinical course and treatment.
Kaislasuo J; Suhonen S; Gissler M; Lähteenmäki P; Heikinheimo O
Hum Reprod; 2013 Jun; 28(6):1546-51. PubMed ID: 23526304
[TBL] [Abstract][Full Text] [Related]
2. Intrauterine contraception: incidence and factors associated with uterine perforation--a population-based study.
Kaislasuo J; Suhonen S; Gissler M; Lähteenmäki P; Heikinheimo O
Hum Reprod; 2012 Sep; 27(9):2658-63. PubMed ID: 22763376
[TBL] [Abstract][Full Text] [Related]
3. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
[TBL] [Abstract][Full Text] [Related]
4. Perforated intraperitoneal intrauterine contraceptive devices: diagnosis, management, and clinical outcomes.
Kho KA; Chamsy DJ
J Minim Invasive Gynecol; 2014; 21(4):596-601. PubMed ID: 24462588
[TBL] [Abstract][Full Text] [Related]
5. The management of intrauterine devices following uterine perforation.
Adoni A; Ben Chetrit A
Contraception; 1991 Jan; 43(1):77-81. PubMed ID: 1825971
[TBL] [Abstract][Full Text] [Related]
6. Risk of uterine perforation with levonorgestrel-releasing and copper intrauterine devices in the European Active Surveillance Study on Intrauterine Devices.
Heinemann K; Reed S; Moehner S; Minh TD
Contraception; 2015 Apr; 91(4):274-9. PubMed ID: 25601352
[TBL] [Abstract][Full Text] [Related]
7. Intrauterine devices: an effective alternative to oral hormonal contraception.
Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
[TBL] [Abstract][Full Text] [Related]
8. Perforation risk and intra-uterine devices: results of the EURAS-IUD 5-year extension study.
Barnett C; Moehner S; Do Minh T; Heinemann K
Eur J Contracept Reprod Health Care; 2017 Dec; 22(6):424-428. PubMed ID: 29322856
[TBL] [Abstract][Full Text] [Related]
9. Uterine perforation by copper intrauterine device.
Heinonen PK; Merikari M; Paavonen J
Eur J Obstet Gynecol Reprod Biol; 1984 Jun; 17(4):257-61. PubMed ID: 6378687
[TBL] [Abstract][Full Text] [Related]
10. Intraperitoneal levonorgestrel-releasing intrauterine device following uterine perforation: the role of progestins in adhesion formation.
Haimov-Kochman R; Doviner V; Amsalem H; Prus D; Adoni A; Lavy Y
Hum Reprod; 2003 May; 18(5):990-3. PubMed ID: 12721174
[TBL] [Abstract][Full Text] [Related]
11. Hormonally impregnated intrauterine systems (IUSs) versus other forms of reversible contraceptives as effective methods of preventing pregnancy.
French R; Van Vliet H; Cowan F; Mansour D; Morris S; Hughes D; Robinson A; Proctor T; Summerbell C; Logan S; Helmerhorst F; Guillebaud J
Cochrane Database Syst Rev; 2004; 2004(3):CD001776. PubMed ID: 15266453
[TBL] [Abstract][Full Text] [Related]
12. Complete and partial uterine perforation and embedding following insertion of intrauterine devices. II. Diagnostic methods, prevention, and management.
Zakin D; Stern WZ; Rosenblatt R
Obstet Gynecol Surv; 1981 Aug; 36(8):401-17. PubMed ID: 6455610
[TBL] [Abstract][Full Text] [Related]
13. Comparative contraceptive effectiveness of levonorgestrel-releasing and copper intrauterine devices: the European Active Surveillance Study for Intrauterine Devices.
Heinemann K; Reed S; Moehner S; Minh TD
Contraception; 2015 Apr; 91(4):280-3. PubMed ID: 25601350
[TBL] [Abstract][Full Text] [Related]
14. Hormonally impregnated intrauterine systems (IUSs), versus other forms of reversible contraceptives as effective methods of preventing pregnancy.
French R; Cowan F; Mansour D; Morris S; Hughes D; Robinson A; Proctor T; Summerbell C; Logan S; Guillebaud J
Cochrane Database Syst Rev; 2001; (2):CD001776. PubMed ID: 11406007
[TBL] [Abstract][Full Text] [Related]
15. Detailed analysis of menstrual bleeding patterns after postmenstrual and postabortal insertion of a copper IUD or a levonorgestrel-releasing intrauterine system.
Suvisaari J; Lähteenmäki P
Contraception; 1996 Oct; 54(4):201-8. PubMed ID: 8922872
[TBL] [Abstract][Full Text] [Related]
16. Safety of levonorgestrel 52 mg intrauterine system compared to copper intrauterine device: a population-based cohort study.
Bosco-Lévy P; Gouverneur A; Langlade C; Miremont G; Pariente A
Contraception; 2019 Jun; 99(6):345-349. PubMed ID: 30871933
[TBL] [Abstract][Full Text] [Related]
17. Complete and partial uterine perforation and embedding following insertion of intrauterine devices. I. Classification, complications, mechanism, incidence, and missing string.
Zakin D; Stern WZ; Rosenblatt R
Obstet Gynecol Surv; 1981 Jul; 36(7):335-53. PubMed ID: 7029368
[TBL] [Abstract][Full Text] [Related]
18. Levonorgestrel-Releasing Intrauterine Contraceptive Device in the Peritoneal Cavity: A Report of Two Cases.
Starič KD; Taneska P; Zore A; Lukanović A; Kobal B; Cvjetićanin B; Jakopič K
J Reprod Med; 2017; 62(3-4):215-17. PubMed ID: 30230800
[TBL] [Abstract][Full Text] [Related]
19. Dislocated intrauterine devices: clinical presentations, diagnosis and management.
Tabatabaei F; Masoumzadeh M
Eur J Contracept Reprod Health Care; 2021 Apr; 26(2):160-166. PubMed ID: 33555216
[TBL] [Abstract][Full Text] [Related]
20. Uterine perforation with the levonorgestrel-releasing intrauterine device: analysis of reports from four national pharmacovigilance centres.
van Grootheest K; Sachs B; Harrison-Woolrych M; Caduff-Janosa P; van Puijenbroek E
Drug Saf; 2011 Jan; 34(1):83-8. PubMed ID: 21142273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
